Healthcare Influenza Diagnostics Market is projected to grow up to XX% CAGR during the forecasting pe...

Influenza Diagnostics Market is projected to grow up to XX% CAGR during the forecasting period 2021-2027.

Influenza is a chronic respiratory infection caused by an Orthomyxoviridae family negative-stranded RNA. Humans are infected with three different influenza viruses: A, B, and C. In most cases, influenza is a mild illness that lasts 1–2 weeks, although it can be serious in extreme cases. An ageing population, increased government anti-influenza programmes, the prevalence of chronic diseases such as diabetes, heart disease, and blood disorders, and the introduction of technologically advanced influenza diagnostic tests are some of the key factors driving growth in the influenza diagnostics market. The influenza diagnostics market report aims to provide an overview of the global influenza diagnostics market, as well as comprehensive market segmentation by type, end user, and geography. During the forecast period, the global influenza diagnostics market is expected to expand rapidly. The report provides key information on the market status of the leading market players, as well as key market developments and opportunities.

Request for a sample report:

Key Driving Factors: Improved Diagnostic Tests for Influenza Infection Are Now Commercially Available

Rapid molecular assays are a modern form of molecular influenza diagnostic test with high precision and specificity, which has been a significant advancement in influenza diagnostics in recent years. The ability to detect respiratory viruses has significantly improved thanks to reverse transcription polymerase chain reaction (RT-PCR) and nucleic acid detection studies. Furthermore, molecular tests for influenza are primarily based on NAT identification of particular identified pathogens. NATs have some advantages over other diagnostic instruments on the market. They have the capacity to detect low levels of all-known influenza pathogens in clinical specimens, are not dependent on the viability of the target microbe, and provide results in a clinically appropriate time frame.

Key Driving Factors: The presence of well-developed healthcare infrastructure, trained practitioners, and technological advances are projected to drive significant growth in the United States over the forecast period. Furthermore, the rising prevalence of influenza in the United States would drive business expansion. Furthermore, rising government initiatives to manufacture advanced technologies with the goal of delivering efficient results for influenza testing is another major factor driving market development.


During the study era, China is expected to see substantial growth in the influenza testing industry. The rapid expansion is due to the growing prevalence of influenza in various parts of China. According to the World Health Organization (WHO), China is one of the major countries infected with the avian influenza A(H7N9) virus, which will boost demand growth over the forecast period.

This report offers the major market player’s profiles, such as are Quidel Corporation, Inc, Abbott Laboratories, Inc., Hologic, Inc, Becton, Dickinson and Company, Danaher CORPORATION, Diasorin sa, Meridian Bioscience, Luminex Corporation, Biomérieux sa, Genmark Diagnostics, Inc, Siemens Healthineers, Thermo Fisher Scientific, Tecan Trading, Sekisui Diagnostics, F. Hoffmann-la Roche AG, SA Scientific, Ltd, Altona Diagnostics GMBH, Coris Bioconcept SPRL and Elitech Group.

Based on End User:The influenza diagnostics market is divided into three segments based on end use: hospitals, clinics, and point of care testing laboratories. The hospital market for influenza diagnostics held the largest market share, but this is expected to gradually slow with the introduction of POCT laboratories that provide reliable results. POCTs are expected to be the fastest growing segment due to factors such as ease of use and use by everyone, as well as the lack of expertise, aside from basic operational knowledge. With the introduction of technologically advanced POCT, the public's and physicians' dependence on these tests has grown dramatically. The laboratory influenza diagnostic market, on the other hand, is expected to rise at a steady CAGR during the study period.

 Influenza Diagnostics Market report has been categorized as below

By Test type

  • Traditional Diagnostic Tests
  • RIDT
  • Viral Culture
  • DFA
  • Serological assays
  • Molecular Diagnostic Tests
  • RT-PCR
  • TMA
  • LAMP
  • Other INNAT
  • Other Molecular Tests

By End-User

  • Hospitals
  • Clinical Laboratories
  • Other End-User

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Access to Full Report Summary:

Published Date : March-2021